Endothelial p53 deletion prevents cardiac fibrosis and heart failure in a mouse model of pressure overload, suggesting endothelial cells as a potential therapeutic target for preserving cardiac function during hypertrophy.
Answers are grounded in this paper and cite their sources.
Endothelial p53 emerges as a research target in pressure overload; animal data leave open translation to human HF therapy.
Our analyses reveal that accumulation of p53 in endothelial cells contributes to blood vessel rarefaction and fibrosis during chronic cardiac pressure overload and suggest that endothelial cells may be a therapeutic target for preserving cardiac function during hypertrophy.
No takes yet. Share an insight, caveat, or question.
Gogiraju et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: